Promega Corporation provides solutions and technical support to the life sciences industry. Its products include automation-robotics, PCR cloning solutions, DNA and RNA purification systems, buffers and reagents, cloning and restriction enzymes, and food and GMO testing tools. The company also offers electrophoresis, gene expression and reporter assay, mutagenesis, protein interaction, protein expression and analysis, RNA interference, transfection, genetic identity, apoptosis, cell viability, drug discovery, immunological detection, in vitro toxicology, and signal transduction products. In addition, it offers licensing opportunities for various technologies, as well as focuses on leveraging RFID technology to solve customers' needs for inventory management solutions. The company’s products are used to understand the molecular basis of life and potential mechanisms of disease, as well as identify targets for drug development; and support molecular diagnostics and human identification. It serves various customers in the life sciences research and drug discovery markets, including laboratories associated with universities, medical research centers, government institutions, and other research institutions, as well as biotechnology, pharmaceutical, energy, agricultural, and chemical companies. The company sells its products through distributors worldwide. It has branch sales and manufacturing locations in San Luis Obispo, California; Sydney, Australia; Leiden, the Netherlands; Mannheim, Germany; Southampton, the United Kingdom; Milan, Italy; Wallisellen, Switzerland; Charbonnieres, France; Madrid, Spain; Tokyo, Japan; Singapore; Beijing and Shanghai, China; and Seoul, South Korea. Promega Corporation was founded in 1978 and is headquartered in Madison, Wisconsin.